CLSDQ
Price
$0.67
Change
-$3.69 (-84.63%)
Updated
Feb 3 closing price
Capitalization
3.51M
Intraday BUY SELL Signals
FBLG
Price
$0.28
Change
-$0.21 (-42.86%)
Updated
Feb 3 closing price
Capitalization
18.45M
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLSDQ vs FBLG

Header iconCLSDQ vs FBLG Comparison
Open Charts CLSDQ vs FBLGBanner chart's image
Clearside Biomedical
Price$0.67
Change-$3.69 (-84.63%)
Volume$96.68K
Capitalization3.51M
FibroBiologics
Price$0.28
Change-$0.21 (-42.86%)
Volume$523.45K
Capitalization18.45M
CLSDQ vs FBLG Comparison Chart in %
CLSDQ
Daily Signal:
Gain/Loss:
FBLG
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLSDQ vs. FBLG commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSDQ is a Hold and FBLG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (CLSDQ: $0.67 vs. FBLG: $0.28)
Brand notoriety: CLSDQ and FBLG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLSDQ: 94% vs. FBLG: 24%
Market capitalization -- CLSDQ: $3.51M vs. FBLG: $18.45M
CLSDQ [@Biotechnology] is valued at $3.51M. FBLG’s [@Biotechnology] market capitalization is $18.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLSDQ’s FA Score shows that 0 FA rating(s) are green whileFBLG’s FA Score has 0 green FA rating(s).

  • CLSDQ’s FA Score: 0 green, 5 red.
  • FBLG’s FA Score: 0 green, 5 red.
According to our system of comparison, both CLSDQ and FBLG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLSDQ’s TA Score shows that 4 TA indicator(s) are bullish while FBLG’s TA Score has 4 bullish TA indicator(s).

  • CLSDQ’s TA Score: 4 bullish, 4 bearish.
  • FBLG’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CLSDQ is a better buy in the short-term than FBLG.

Price Growth

CLSDQ (@Biotechnology) experienced а -22.63% price change this week, while FBLG (@Biotechnology) price change was -25.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

FBLG is expected to report earnings on Apr 06, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBLG($18.4M) has a higher market cap than CLSDQ($3.51M). FBLG YTD gains are higher at: 23.299 vs. CLSDQ (-4.965). CLSDQ has higher annual earnings (EBITDA): -14.37M vs. FBLG (-17.74M). CLSDQ has more cash in the bank: 6.8M vs. FBLG (4.87M). CLSDQ has less debt than FBLG: CLSDQ (446K) vs FBLG (7.11M). CLSDQ has higher revenues than FBLG: CLSDQ (3.33M) vs FBLG (0).
CLSDQFBLGCLSDQ / FBLG
Capitalization3.51M18.4M19%
EBITDA-14.37M-17.74M81%
Gain YTD-4.96523.299-21%
P/E RatioN/AN/A-
Revenue3.33M0-
Total Cash6.8M4.87M140%
Total Debt446K7.11M6%
FUNDAMENTALS RATINGS
CLSDQ: Fundamental Ratings
CLSDQ
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLSDQFBLG
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLSDQ
Daily Signal:
Gain/Loss:
FBLG
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTSI226.71-1.85
-0.81%
MACOM Technology Solutions Holdings
ABM45.65-0.72
-1.55%
ABM Industries
AISP2.89-0.10
-3.34%
Airship AI Holdings
AVR5.92-0.23
-3.74%
Anteris Technologies Global Corp
CETY0.58-0.12
-17.70%
Clean Energy Technologies Inc.

CLSDQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLSDQ has been loosely correlated with NEVPF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CLSDQ jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSDQ
1D Price
Change %
CLSDQ100%
-21.62%
NEVPF - CLSDQ
35%
Loosely correlated
N/A
ACLX - CLSDQ
34%
Loosely correlated
-0.01%
ANEB - CLSDQ
32%
Poorly correlated
-0.75%
ABVX - CLSDQ
31%
Poorly correlated
+1.67%
IMNN - CLSDQ
30%
Poorly correlated
N/A
More

FBLG and

Correlation & Price change

A.I.dvisor tells us that FBLG and OCUL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FBLG and OCUL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBLG
1D Price
Change %
FBLG100%
-2.26%
OCUL - FBLG
32%
Poorly correlated
-6.99%
IDYA - FBLG
29%
Poorly correlated
+0.50%
PRQR - FBLG
29%
Poorly correlated
+2.58%
CLSDQ - FBLG
29%
Poorly correlated
-21.62%
RXRX - FBLG
29%
Poorly correlated
-1.91%
More